ArticleNature communications2021

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.

Timothy Kottke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.